Metabolic syndrome--neurotrophic hypothesis

Area of Science:

• Neuroscience
• Immunology
• Endocrinology
• Metabolic Research

Background:

• Metabolic syndrome (MetSyn) pathophysiology is complex, involving sympathetic activity, HPA axis, infections, cytokines, adipocytokines, and stress.
• Neurotrophins and mastocytes are implicated in inflammatory/immune diseases and recently shown to affect carbohydrate and lipid metabolism.

Purpose of the Study:

• To investigate the role of neurotrophins in metabolic syndrome pathogenesis.
• To propose a novel hypothesis for metabolic syndrome etiopathogenesis based on neuro-immune-endocrine interactions.

Main Methods:

• Plasma levels of nerve growth factor (NGF) were measured in early and generalized stages of metabolic syndrome.
• A hypothesis was formulated linking inflammatory cytokines, NGF, autonomous nervous system, NPY, HPA axis, mastocytes, and insulin resistance.
• A 6-month non-steroid anti-inflammatory treatment was administered to patients with MetSyn (results in separate publication).

Main Results:

• Early-stage MetSyn showed increased plasma NGF levels.
• Generalized-stage MetSyn exhibited statistically decreased plasma neurotrophin levels compared to controls.
• The proposed hypothesis integrates key pathways contributing to MetSyn development.

Conclusions:

• Neurotrophin deficit likely plays a significant pathogenic role in the generalized stage of metabolic syndrome.
• The neuro-immune-endocrine interaction hypothesis provides a framework for understanding MetSyn development.
• Further research and therapeutic interventions targeting these pathways are warranted.